MedTrace Logo

Anxiety Sensitivity Program for Smoking Cessation

NCT00387049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2010-10-22

No results posted yet for this study

Summary

The purpose of this study is to develop and test a smoking cessation intervention for persons who are specifically sensitive to anxiety and anxiety-related bodily sensations.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Anxiety Sensitivity Program for Smoking Cessation

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Vermont

    lead OTHER

Principal Investigators

  • Michael J. Zvolensky, Ph.D. · University of Vermont, Department of Psychology

  • Andrew R. Yartz, Ph.D. · University of Vermont, Department of Psychology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2009-08-31
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00387049 on ClinicalTrials.gov